- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05206630
ED Physical Therapy for Chronic Low Back Pain
October 10, 2025 updated by: Howard Kim, Northwestern University
An Ancillary Cluster-Randomized Trial of Embedded Physical Therapy for Chronic Low Back Pain
Emergency department (ED)-initiated physical therapy is a rapidly growing resource and represents a promising treatment approach to low back pain.
This clinical trial will evaluate an innovative model of an emergency department "embedded" physical therapist to treat patients with chronic low back pain, with a focus on improving patient functioning and reducing opioid use.
Study Overview
Detailed Description
This trial is ancillary to an ongoing single-center physician-randomized trial of an embedded physical therapy intervention versus usual care in ED patients with acute low back pain (NEED-PT, NCT04921449), comparing a primary outcome of pain-related functioning and a secondary outcome of opioid use at three months.
The main trial aims to enroll up to 360 participants with acute low back pain, defined as ≤ 30 days in duration and no history of lumber surgery or chronic low back pain.
Using the same procedures and physician-randomization assignments as the main trial, this ancillary trial will enroll an additional 200 participants with chronic low back pain (i.e.
non-acute low back pain) in order to obtain initial point estimates for the outcomes of interest and assess participant enrollment and retention rates in this population.
The ancillary trial's sample size of 200 participants is an estimate of patient accrual over the anticipated remaining duration of the main trial (i.e., there is not a separate power calculation for this ancillary trial given its exploratory nature), and the actual number accrued may differ depending on the main trial's actual end date.
Study Type
Interventional
Enrollment (Actual)
128
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age ≥ 18 years
- Low back pain (originating between 12th rib and buttocks)
- Evaluated by a physician randomized to either study arm
- Evaluated when ED physical therapy is available (e.g., Mon-Fri, 8am-4pm)
- Likely to be discharged home (based on physician assessment)
- Ability to complete follow-up data collection electronically or by telephone
- English-speaking
Exclusion Criteria:
- Enrollment in the main trial (NEED-PT, NCT04921449)
- Serious red-flag signs/symptoms (bladder/bowel incontinence, saddle anesthesia, debilitating motor weakness)
- Obvious non-musculoskeletal etiology for low back pain (e.g., shingles, kidney stone)
- Other concomitant injuries or pain (e.g., closed head injury, shoulder pain)
- Unable to ambulate at baseline
- Known pregnancy, under police custody, unable to consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Embedded ED Physical Therapy
An ED physical therapist will be embedded with the primary treatment team to evaluate patients presenting with low back pain at the beginning of the overall treatment course.
The physical therapist will utilize a clinical protocol that matches the patient's history and exam findings to an appropriate treatment classification consisting of directional preference exercises, manual traction, stabilization exercises, non-thrust manipulation/mobilization, and/or psychologically informed rehabilitation.
The embedded PT intervention will supplement any usual care performed by the treating physician.
|
All ED Physical Therapy treatment classifications involve a combination of exercise, range of motion, education, prognostic guidance, and reassurance.
Patients are provided with an individualized home exercise plan based on their matched treatment classification and/or active rest.
|
|
No Intervention: Usual Care
Usual care consists of any ED testing or treatment not involving an ED physical therapist in accordance with the treating physician's usual and customary practice.
This could include diagnostic imaging, patient education and reassurance, and administration and/or prescribing of analgesic medications.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PROMIS Pain Interference (PROMIS-PI)
Time Frame: Three months after the index ED visit.
|
PROMIS-PI measures the self-reported consequences of pain on relevant aspects of a person's life, including social, cognitive, emotional, physical, and recreational activities.
The investigators will use the computer-adaptive format to minimize respondent burden.
Scores are standardized to the general U.S. population, with a score of 50 representing the population mean.
The time frame of interest for the PROMIS-PI is "in the past 7 days," meaning that participants provide responses based on their symptoms over the last week.
|
Three months after the index ED visit.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Oswestry Disability Index (ODI)
Time Frame: Three months after the index ED visit.
|
The ODI contains 10 questions relating to low back pain intensity, personal care, lifting, walking, sitting, standing, sleeping, social life, traveling, and employment/homemaking.
The ODI score ranges from zero (no disability) to 100 (maximum disability).
The time frame of interest for the ODI is "today," meaning that participants provide responses based on their current symptoms on the day of survey response.
The modified ODI replaces an item from the original ODI pertaining to sex life with a new item pertaining to employment/homemaking.
|
Three months after the index ED visit.
|
|
Patient-Reported Opioid Use in Last 24 Hours
Time Frame: Three months after the index ED visit.
|
Patient-reported opioid use will be collected using a customized instrument assessing whether participants have taken any opioid medication in the last 24 hours (binary yes/no).
The 24-hour timeframe was selected to maximize accuracy in patient recall and has been used previously.
In brief, opioid medications are listed by brand and generic names; a "yes" response to any medication triggers an additional query asking the participant to specify the medication dose (e.g., oxycodone 10mg) and quantity (e.g., four pills), allowing for standardization by morphine milligram equivalents.
|
Three months after the index ED visit.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Opioid Prescription Filling
Time Frame: Three months after the index ED visit.
|
Opioid prescription filling data will be queried in the state prescription monitoring database.
|
Three months after the index ED visit.
|
|
Patient-Reported Prescription Analgesic Use in Last 24 Hours
Time Frame: Three months after the index ED visit.
|
Patient-reported prescription analgesic use will be collected using the same customized instrument described above for opioid use.
Prescription analgesics include the following: opioids, benzodiazepines, skeletal muscle relaxants, and gabapentinoids.
|
Three months after the index ED visit.
|
|
Prescription Analgesic Filling
Time Frame: Three months after the index ED visit.
|
Prescription analgesic filling data will be queried in the state prescription drug monitoring database.
Prescription analgesics include opioids, benzodiazepines, skeletal muscle relaxants, and gabapentinoids.
|
Three months after the index ED visit.
|
|
Numeric Pain Rating Scale (NPRS)
Time Frame: Three months after the index ED visit.
|
The NPRS measures pain intensity from 0 to 10 (higher score indicates higher intensity) and is easily understood by laypersons, clinicians, and researchers.
The investigators will assess a single item relating to average pain intensity over the last 24 hours.
|
Three months after the index ED visit.
|
|
Global Rating of Change (GROC)
Time Frame: Three months after the index ED visit.
|
The GROC is a single-item survey used to evaluate overall recovery from low back pain from "the time that you began having pain until now."
Responses are provided on a 15-point Likert scale ranging from "a very great deal worse" to "a very great deal better" (higher scores indicate better outcome).
|
Three months after the index ED visit.
|
|
Pain Catastrophizing Scale (PCS-4)
Time Frame: Three months after the index ED visit.
|
The original PCS is a 13-item survey measuring the degree to which an individual catastrophizes in response to pain.
PCS scores correlate closely with pain intensity and disability over time; higher PCS scores are associated with progression from acute to chronic pain.
The investigators will utilize the brief 4-item PCS measure containing original items 3, 6, 8, and 11 (total score range 0-16, higher score indicates higher catastrophizing).
|
Three months after the index ED visit.
|
|
Pain Self-Efficacy Questionnaire (PSEQ-4)
Time Frame: Three months after the index ED visit.
|
The original PSEQ is a 10-item survey measuring the confidence with which individuals can do things despite pain.
The investigators will utilize the brief 4-item PSEQ measure containing original items 4, 6, 8, and 9 (total score range 0-24, higher score indicates higher confidence).
|
Three months after the index ED visit.
|
|
Advanced Healthcare Resource Utilization
Time Frame: Three months after the index ED visit.
|
The investigators will assess the proportion of participants who utilized any advanced healthcare resources for low back pain after their index ED visit, defined as advanced imaging (e.g., magnetic resonance imaging) or procedures/surgery (e.g., epidural steroid injection, lumbar discectomy).
|
Three months after the index ED visit.
|
|
ED Diagnostic Imaging Utilization
Time Frame: Index ED 1 day visit.
|
The investigators will assess the proportion of ED visits in which any diagnostic imaging of the lower back was performed, including plain radiography, computed tomography, or magnetic resonance imaging.
|
Index ED 1 day visit.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Howard S Kim, MD MS, Northwestern University Feinberg School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 11, 2022
Primary Completion (Actual)
October 3, 2024
Study Completion (Actual)
July 25, 2025
Study Registration Dates
First Submitted
January 11, 2022
First Submitted That Met QC Criteria
January 11, 2022
First Posted (Actual)
January 25, 2022
Study Record Updates
Last Update Posted (Estimated)
October 14, 2025
Last Update Submitted That Met QC Criteria
October 10, 2025
Last Verified
October 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Organizing Pneumonia
- Pain
- Neurologic Manifestations
- Pathologic Processes
- Disease Attributes
- Immune System Diseases
- Respiratory Tract Diseases
- Lung Diseases
- Bronchial Diseases
- Lung Diseases, Obstructive
- Back Pain
- Bronchiolitis Obliterans
- Bronchiolitis
- Bronchitis
- Graft vs Host Disease
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Bronchiolitis Obliterans Syndrome
- Emergencies
- Low Back Pain
Other Study ID Numbers
- STU00213134
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.